Determination of debrisoquine oxidation phenotype in healthy volunteers during phase I trials
Therapie
.
1996 Mar-Apr;51(2):191-2.
Authors
I Girard
,
S Ferry
,
P Nony
,
J P Boissel
PMID:
8763055
No abstract available
Publication types
Clinical Trial
Clinical Trial, Phase I
Letter
MeSH terms
Adolescent
Adult
Debrisoquin / metabolism*
Healthy Worker Effect
Humans
Male
Oxidation-Reduction
Phenotype
Volunteers
Substances
Debrisoquin